C4 Therapeutics CFO Adams assumes principal accounting officer; Mossler departs

C4 Therapeutics, Inc.

Mark Mossler to cease as Chief Accounting Officer effective May 15, 2026; departure not due to any disagreement.
CFO Kendra R. Adams designated as principal accounting officer, effective May 15, 2026.
Adams receives no additional compensation for assuming the additional role.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.